🇺🇸 GP2015 in United States

6 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Arthralgia — 1 report (16.67%)
  2. C-Reactive Protein Increased — 1 report (16.67%)
  3. Nasopharyngitis — 1 report (16.67%)
  4. Pneumonia — 1 report (16.67%)
  5. Tibia Fracture — 1 report (16.67%)
  6. White Blood Cell Count Increased — 1 report (16.67%)

Source database →

Other Oncology approved in United States

Frequently asked questions

Is GP2015 approved in United States?

GP2015 does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for GP2015 in United States?

Sandoz is the originator. The local marketing authorisation holder may differ — check the official source linked above.